1. Medtech Insight
  2. >>Business
  3. >>R&D

AI Expert: Awareness Is Key To Managing Biases

A Walden University professor discussed various types of biases AI/ML developers need to take into consideration during the recent Xavier Health AI Summit. She noted a working group will produce a white paper laying out different types of biases to raise awareness.

Concept illustration of a digital man meditating while paper swans fly by

Betsy Macht, a professor of management and technology at Walden University, says the key to overcoming biases in artificial intelligence/ machine learning (AI/ML) product development is knowing that they exist.

Speaking via webcast during a seminar at Xavier Health’s annual AI Summit, Macht discussed how different types of biases can crop up in AI products and may adversely

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from R&D

Data Finds Capillary Blood Is A Reliable Alternative To Venous Blood For Routine Testing

 
• By Natasha Barrow

A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.

Mirvie Launches Predictive Blood Test For Preeclampsia

 
• By Marion Webb

Mirvie launched Encompass, a blood test to help identify women over age 35 who are at moderate risk for preeclampsia, and will conduct additional studies to support reimbursements from payers.

More from Business